World Bulletin / News Desk
Breast cancer cells can destroy a powerful immune response in the body and allow the disease to spread to the patient's bones, researchers in Australia reported on Monday.
They also experimented with two ways to reinstate this immune response to help patients fight breast cancer, but it will take more tests and several more years for these therapies to become routine treatments, they said.
"We have identified a way that breast cancer cells can turn off the immune system, allowing them to spread to distant parts such as the bone," said Belinda Parker, a research fellow at the Peter MacCallum Cancer Centre in Melbourne, who led the study.
"By understanding how this occurs, we hope to use existing and new therapies to restore this immune function and prevent the spread of cancer," she said by telephone.
The study was published on Monday in the peer-reviewed journal Nature Medicine.
In 2010, 1.5 million people were diagnosed with breast cancer, the top cancer in women around the world.
Although it kills many women in developing countries, 89 percent of women diagnosed with breast cancer in western countries are still alive five years after diagnosis thanks to detection tests and treatment.
Using tissue samples from breast cancer patients and experiments with mice, Parker and colleagues found that a gene called IRF7 is switched off in patients whose cancer spreads to other parts of the body.
IRF7 controls the production of interferon, an important type of immune protein that fights viruses and bacteria apart from tumour cells
"Usually when breast cancer cells leave the breast and travel in the bloodstream and into bone marrow, the release of interferons by IRF7 will cause the immune system to recognise those cells and eliminate them," Parker said.
"But by losing IRF7, it prevents the stimulation of immune responses and allows those cells to hide from being recognised (and later spread)."
Parker and her team tried two ways to revive this immune response in mice experiments and both appeared to work.
"We put the gene back into cancer cells so it can't switch it (IRF7) off. We allowed the immune pathway to be stimulated and the cancer cells did not spread to the bone," Parker said.
"The other way is to treat the animals with interferon, which is available for treating other diseases, like hepatitis. That also prevented the spread of cancer to the bone."
Parker said they will study how best to use these two methods on patients in the next few years and plan to have a clinical trial in two to three years.
MSF is discussing whether to shorten some Ebola assignments from their current duration of four to six weeks
The recent surge in cases, now numbering 32 since the start of October, has been focused in Riyadh and the western city of Taif
The meeting organized by ALBA, a bloc of leftist-governed countries, aims to coordinate a regional strategy on the prevention and control of Ebola
U.N. Secretary-General Ban Ki-moon has voiced his regret that health workers returning from Ebola-stricken countries in West Africa were quarantined.
In a research carried out in the U.S. reveals alarming findings about spending on illicit drugs -over $100 billion
The Township Owl Project takes juvenile birds rescued from perilous situations, such as when a building where they nested in is demolished, and gives them a new home and a new job
The three worst-hit countries of West Africa - Guinea, Liberia and Sierra Leone - account for the bulk, recording 4,912 deaths out of 10,114 cases
There are 883 confirmed cases of the deadly virus, out of which 319 people have died since 2012, the WHO says
WHO announces one million doses of Ebola vaccine to be produced in 2015
That pact would aim to improve on two decades of stuttering cooperation and rein in emissions of carbon dioxide blamed for a disruptive rise in temperatures
The World Health Organization last month urged the use of blood-derived products and serum from survivors.
Pentagon rapid-response Ebola medical team was scheduled to begin training at Fort Sam Houston in San Antonio, Texas
Extensively drug-resistant TB (XDR-TB), which is even more expensive and difficult to treat than multi drug-resistant (MDR-TB) strains, has now been reported in 100 countries around the world.
Device can be used in the field without special equipment, according to developers
The technique involved transplanting what are known as olfactory ensheathing cells into the patient's spinal cord and constructing a "nerve bridge" between two stumps of the damaged spinal column.
The meeting in Cuba is aimed at keeping Ebola at bay and it brings together senior officials from the ALBA bloc of nations